Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated.

Dr. Dansey, formerly of Pfizer and Seagen, strengthens the Board’s research, drug development and commercialization expertise ...

Nov 5 (Reuters) - Pfizer (PFE.N) plans to sweeten its bid for Metsera (MTSR.O), a person familiar with the matter told ...

Novo Nordisk, maker of Ozempic and Wegovy, lowered its 2025 sales outlook for the fourth time, citing slower growth in diabetes and obesity treatments ...

After a difficult birth and a decade at Pfizer, she left corporate life to fix maternal care for Black women. Her startup, Mae, now partners with Medicaid programs nationwide and is changing how ...

Q3 2025 Management View CEO Albert Bourla highlighted that "the past few months have been pivotal for Pfizer" with key developments including an agreement with the U.S. government, the proposed ...

Dow Jones Top Company Headlines at 9 AM ET: Pfizer Profit Falls Amid Lower Covid-19 Drug Demand | Hormel ... Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral ...

LONDON (Reuters) -Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its ...

Had Pfizer’s Freda Lewis-Hall not stepped in, SpringWorks' rare disease treatment may never have reached patients. Pharmas ...

A survey by CareerMinds revealed the best company to work for in each state for career opportunities. Here's Louisiana's best ...

Pfizer is racing towards patent cliffs that will lead to even worse financial results. Vertex Pharmaceuticals is posting strong revenue growth and excellent clinical progress. Pfizer's financial ...

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the December 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...